MIR363, a type of microRNA, has been investigated in the context of prostate cancer (PCa) [PMC10067432]. Research utilizing RIP assays has demonstrated that MIR363, along with miR708 and circEZH2E2/E3, can be identified in immunoprecipitates obtained with anti-Ago2 [PMC10067432]. Additionally, the levels of MIR363 and miR708 were found to be significantly lower in PCa tissue samples and PCa cells (PC3 and DU145) compared to benign prostatic hyperplasia (BPH) [PMC10067432]. These findings suggest a potential involvement of MIR363 in the development or progression of PCa [PMC10067432].
u gu CA A gaugagua guu CGGGUGGAU CG UGCAAUUUu u ||| ||||||||| || ||||||||| caa GUCUACCUA GC ACGUUAAaa c c AU UG - agaggaua
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0003385 |
Description | Homo sapiens hsa-miR-363-5p mature miRNA |
Sequence | 7 - CGGGUGGAUCACGAUGCAAUUU - 28 |
Evidence |
experimental
cloned [2-3] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
Accession | MIMAT0000707 |
Description | Homo sapiens hsa-miR-363-3p mature miRNA |
Sequence | 50 - AAUUGCACGGUAUCCAUCUGUA - 71 |
Evidence |
experimental
array-cloned [1], cloned [2-3] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|